Terms: = Uterine cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Treatment
60 results:
1. Effects of brd4 inhibitor JQ1 on the expression profile of super-enhancer related lncRNAs and mRNAs in cervical cancer HeLa cells.
Zheng J; Huang B; Xiao L; Wu M
PeerJ; 2024; 12():e17035. PubMed ID: 38410799
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and feasibility of 3D printed redesigned Venezia™ applicator for treating advanced cervix and recurrent endometrial cancer.
Lee VWY; Yip WWL; Tang SYK; Leung MPH; Kwan KKK; Liu ACH; Chan VNY; Wu JWS; Cheng JNS; Chiang CL; Ho-Fun Lee V
Phys Med; 2023 Oct; 114():103150. PubMed ID: 37757501
[TBL] [Abstract] [Full Text] [Related]
3. Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
Saito A; Nishikawa T; Yoshida H; Mizoguchi C; Kitadai R; Yamamoto K; Yazaki S; Kojima Y; Ishikawa M; Kato T; Yonemori K
Gynecol Oncol; 2023 Sep; 176():115-121. PubMed ID: 37506533
[TBL] [Abstract] [Full Text] [Related]
4. HER2 IHC Expression and Gene Amplification in p53-aberrant High-grade Endometrial Endometrioid Carcinoma Suggests That This Population May Benefit From HER2 Testing and Targeted Therapy.
Joehlin-Price AS; Komforti MK; Ladwig NR; Devine P; Hoyle C; McCoy L; Sprague C; Astbury C; Hoda R; Chen YY; Garg K
Am J Surg Pathol; 2023 May; 47(5):580-588. PubMed ID: 36939053
[TBL] [Abstract] [Full Text] [Related]
5. The statuses of HER2 expression and mismatch repair in endometrial clear cell carcinoma.
Bayramoglu Z; Erozbek SY; Ozdemir IA; Ulker V; Muezzinoglu B
Pathol Res Pract; 2023 Jan; 241():154258. PubMed ID: 36516643
[TBL] [Abstract] [Full Text] [Related]
6. Deregulation of SPOP in cancer.
Zhang H; Jin X; Huang H
Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
[TBL] [Abstract] [Full Text] [Related]
7. The brd4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer.
Pang Y; Bai G; Zhao J; Wei X; Li R; Li J; Hu S; Peng L; Liu P; Mao H
J Transl Med; 2022 Jul; 20(1):336. PubMed ID: 35902869
[TBL] [Abstract] [Full Text] [Related]
8. Adequacy of Histopathology Reports Representing Oncologic Resection Specimens: An Experience of Reporting Practice in Rural India.
Bansal S; Sali AP; Sancheti S; Somal PK; Khandelwal S; Goel AK; Kapoor R
Arch Pathol Lab Med; 2022 Nov; 146(11):1378-1386. PubMed ID: 35213894
[TBL] [Abstract] [Full Text] [Related]
9. Updated Review on Pathology of Endocervical Adenocarcinoma with Emphasis on Clinically Relevant Findings.
Cimic A; Liu-Jarin X
Acta Med Acad; 2021 Apr; 50(1):126-135. PubMed ID: 34075768
[TBL] [Abstract] [Full Text] [Related]
10. brd4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair.
Ni M; Li J; Zhao H; Xu F; Cheng J; Yu M; Ke G; Wu X
Oncogene; 2021 Apr; 40(15):2711-2724. PubMed ID: 33712705
[TBL] [Abstract] [Full Text] [Related]
11. Synergistic Therapy for Cervical cancer by Codelivery of Cisplatin and JQ1 Inhibiting Plk1-Mutant Trp53 Axis.
Wang Y; Shen N; Li S; Yu H; Wang Y; Liu Z; Han L; Tang Z
Nano Lett; 2021 Mar; 21(6):2412-2421. PubMed ID: 33705152
[TBL] [Abstract] [Full Text] [Related]
12. Photodynamic and Cold Atmospheric Plasma Combination Therapy Using Polymeric Nanoparticles for the Synergistic treatment of Cervical cancer.
Ha JH; Kim YJ
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33504007
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Effects and Tissue Penetration Depth of Physical Plasma in Human Mucosa Analyzed by Contact- and Marker-Independent Raman Microspectroscopy.
Wenzel T; Carvajal Berrio DA; Daum R; Reisenauer C; Weltmann KD; Wallwiener D; Brucker SY; Schenke-Layland K; Brauchle EM; Weiss M
ACS Appl Mater Interfaces; 2019 Nov; 11(46):42885-42895. PubMed ID: 31657892
[TBL] [Abstract] [Full Text] [Related]
14. Robot-assisted surgery for benign distal ureteral strictures: step-by-step technique using the SP
Kaouk JH; Garisto J; Eltemamy M; Bertolo R
BJU Int; 2019 Apr; 123(4):733-739. PubMed ID: 30499629
[TBL] [Abstract] [Full Text] [Related]
15. brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapy.
Rataj O; Haedicke-Jarboui J; Stubenrauch F; Iftner T
Int J Cancer; 2019 May; 144(9):2330-2338. PubMed ID: 30421459
[TBL] [Abstract] [Full Text] [Related]
16. See, Test & Treat: A 5-Year Experience of Pathologists Driving Cervical and Breast cancer Screening to Underserved and Underinsured Populations.
Magnani B; Harubin B; Katz JF; Zuckerman AL; Strohsnitter WC
Arch Pathol Lab Med; 2016 Dec; 140(12):1411-1422. PubMed ID: 27922769
[TBL] [Abstract] [Full Text] [Related]
17. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
[TBL] [Abstract] [Full Text] [Related]
18. ERK8 is a novel HuR kinase that regulates tumour suppressor PDCD4 through a miR-21 dependent mechanism.
Liwak-Muir U; Dobson CC; Naing T; Wylie Q; Chehade L; Baird SD; Chakraborty PK; Holcik M
Oncotarget; 2016 Jan; 7(2):1439-50. PubMed ID: 26595526
[TBL] [Abstract] [Full Text] [Related]
19. HER2 immunohistochemistry significantly overestimates HER2 amplification in uterine papillary serous carcinomas.
Mentrikoski MJ; Stoler MH
Am J Surg Pathol; 2014 Jun; 38(6):844-51. PubMed ID: 24698965
[TBL] [Abstract] [Full Text] [Related]
20. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats.
Mikell JK; Klopp AH; Price M; Mourtada F
Brachytherapy; 2013; 12(6):645-53. PubMed ID: 23891341
[TBL] [Abstract] [Full Text] [Related]
[Next]
